The rise in reported number of TB cases in the state of Andhra Pradesh swung one of the most reputed medical institutions in the state in to action. Based on a clear priority to provide treatment for TB, the Rajiv Gandhi Institute of Medical Sciences (RIMS) has recently commenced TB tests center at its premise.
This new development is aimed at provided convenience to many patients who were earlier required to travel long distances to get them tested. The new centre at RIMS is equipped with advanced tests facility in Srikakulam district itself.
As confirmed by Hindu, The patients were forced to travel to Visakhapatnam or Vizianagaram for advanced tests with the lack of facility locally. Srikakulam MP Kinjarapu Rammohan and Srikakulam MLA Gunda Lakshmi Devi inaugurated the testing centre in RIMS and directed the officials to maintain the equipment properly. Srikakulam Collector P. Lakshmi Narasimham explained the steps being taken for the overall development of RIMS at the district headquarters.
Hundreds of patients suffering from tuberculosis can have tests in Srikakulam itself, thanks to establishment of TB testing centre in the Rajiv Gandhi Institute of Medical Sciences (RIMS).
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!